20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T82261 | Grb2 SH2 domain inhibitor 1 | ||
Grb2 SH2 Domain Inhibitor 1 is a cyclic cell-penetrating peptide (CPP) featuring a conformationally restricted d-pro-l-pro motif ring (AF Φ Rpprrfq), where Φ represents L-naphthylalanine, R denotes D-arginine, and P indi... | |||
T77994 | Grb2 SH2 domain inhibitor 1 TFA | ||
Grb2 SH2 Domain Inhibitor 1 TFA is a cyclic cell-penetrating peptide (CPP) featuring a conformationally restricted d-pro-l-pro motif ring (AF Φ Rpprrfq), where Φ represents L-naphthylalanine, R signifies D-arginine, and ... | |||
T9339 | Stafia-1 | STAT | |
Stafia-1 is a potent STAT5a inhibitor ( IC50=22.2 μM). Stafia-1 displays high selectivity over STAT5b and other STAT family members. | |||
T6308 | Stattic | STAT3 Inhibitor V | Apoptosis , STAT |
Stattic (STAT3 Inhibitor V) is a STAT3 inhibitor (IC50=5.1 μM) that selectively inhibits STAT3 activation, dimerization, and nuclear translocation. Stattic has antitumor activity and induces apoptosis. | |||
T9723 | GluR6 antagonist-1 | Src | |
GluR6 antagonist-1 inhibits the pY binding site of tyrosine kinase p56lck SH2 domain. | |||
T10877 | CPDA | Phosphatase | |
CPDA is a new potent inhibitor of SH2 domain-containing inositol phosphatase 2 (SHIP2). | |||
T4216 | STAT5-IN-1 | STAT5 Inhibitor | STAT |
STAT5-IN-1 (STAT5 Inhibitor) is a cell-permeable inhibitor which suppresses Stat5 via binding to the SH2 domain. | |||
T14037 | 3α-Aminocholestane | 5α-Cholestan-3α-amine | Phosphatase |
3α-Aminocholestane (5α-Cholestan-3α-amine) is a potent inhibitor of inositol-5'-phosphatase 1 (SHIP1) containing the SH2 structural domain (IC50 : 2.5 μM) for research and immune-related diseases. | |||
TQ0003L1 | 740 Y-P acetate | PDGFR 740Y-P Acetate,740YPDGFR acetate,740 Y-P acetate(1236188-16-1 Free base) | PI3K |
740 Y-P acetate (740YPDGFR acetate) is a potent and cell-permeable PI3K activator.740 Y-P acetate tends to bind to GST fusion proteins containing the N- and C-terminal SH2 structural domains of p85, but not to GST alone. | |||
T14327 | AS1949490 | Phosphatase | |
AS1949490 activated glucose metabolism via up-regulation of GLUT1 gene in L6 myotubes[1][2]. AS1949490 is a potent and selective SHIP-2 (SH2 domain-containing inositol 5′ phosphatase 2) inhibitor, with an IC50 of 620 nM. | |||
T62491 | STAT3-IN-13 | STAT | |
STAT3-IN-13 is a potent STAT3 inhibitor.STAT3-IN-13 has antiproliferative and anticancer activity and acts by binding to the structural domain of STAT3 SH2.STAT3-IN-13 inhibits the phosphorylation of STAT3 Y705, which in... | |||
TQ0003 | 740 Y-P | 740YPDGFR,PDGFR 740Y-P | PI3K , Autophagy |
740 Y-P (740YPDGFR) is a potent and cell-permeable activator of PI3K. | |||
T27707 | K118 | K 118,K-118 | |
K118 is an inhibitor of SH2-containing inositol 5' phosphatase 1 (SHIP1). It reverses diet- and age-associated obesity and metabolic syndrome. | |||
T30089 | AP-22161 | AP22161,G7VE62573J,UNII-G7VE62573J,SCHEMBL7243003,AP 22161 | |
AP-22161 selectively binds the Src SH2 domain by targeting highly conserved phosphotyrosine binding to cysteine residues in the pocket. AP-22161 selectively inhibits Src SH2 binding and can be used to inhibit osteoclast ... | |||
T23751 | AQX-MN115 | ||
AQX-MN115 is an SH2- containing inositol 5- phosphatase modulator. | |||
T38965 | EPQpYEEIPIYL | ||
EPQpYEEIPIYL, a phosphopeptide, is a ligand for the Src homology 2 (SH2) domain. It activates members of the Src family, such as Lck, Hck, and Fyn, through the binding interaction with SH2 domains. | |||
T40219 | CGP78850 | ||
CGP78850 is a potent and selective Grb2 SH2-phosphopeptide interaction antagonist that holds potential for cancer research. | |||
T12905 | SI-109 | STAT | |
SI-109 is a potent inhibitor of STAT3 SH2 domain (Ki=9 nM),and with antitumor activity. | |||
TP2085 | Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH | N-Acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu | |
Phosphopeptide ligand for the src SH2 domain (IC50 = 1 μM). Blocks src interactions with EGFR and FAK. | |||
T24838 | Stafib-1 | Stafib 1,Stafib1 | STAT |
Stafib-1 is a selective inhibitor of STAT5β targeting SH2 domain with an IC50 of 154 nM and a Ki of 44 nM. |